EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antidiabetic Activity of Potential Probiotics Limosilactobacillus spp., Levilactobacillus spp., and Lacticaseibacillus spp. Isolated from Fermented Sugarcane Juice: A Comprehensive In Vitro and In Silico Study

Chandana Kumari V B iD, Sujay S Huligere iD, Ghallab Alotaibi, Abdulaziz K Al Mouslem iD, Ammar Abdulraheem Bahauddin, Thippeswamy Boreddy Shivanandappa iD, Ramith Ramu

Nutrients · 13.04.2023 · 15 (8) · 1882

DOI: 10.3390/nu15081882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 13.04.2023. Verfasst von Chandana Kumari V B und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India. Hauptthemen laut MEDLINE: Saccharum, Probiotics. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Probiotics are regarded as a potential source of functional foods for improving the microbiota in human gut. When consumed, these bacteria can control the metabolism of biomolecules, which has numerous positive effects on health. Our objective was to identify a probiotic putative Lactobacillus spp. from fermented sugarcane juice that can prevent α-glucosidase and α-amylase from hydrolyzing carbohydrates. Isolates from fermented sugarcane juice were subjected to biochemical, molecular characterization (16S rRNA) and assessed for probiotic traits. Cell-free supernatant (CS) and extract (CE) and also intact cells (IC) were examined for the inhibitory effect on α-glucosidase and α-amylase. CS of the strain showed the highest inhibition and was subjected to a liquid chromatography–mass spectrometry (LCMS) analysis to determine the organic acid profile. The in silico approach was employed to assess organic acid stability and comprehend enzyme inhibitors’ impact. Nine isolates were retained for further investigation based on the preliminary biochemical evaluation. Limosilactobacillus spp., Levilactobacillus spp., and Lacticaseibacillus spp. were identified based on similarity > 95% in homology search (NCBI database). The strains had a higher survival rate (>98%) than gastric and intestinal fluids, also a high capacity for adhesion (hydrophobicity > 56%; aggregation > 80%; HT-29 cells > 54%; buccal epithelial cells > 54%). The hemolytic assay indicated that the isolates could be considered safe. The isolates’ derivatives inhibited enzymes to varying degrees, with α-glucosidase inhibition ranging from 21 to 85% and α-amylase inhibition from 18 to 75%, respectively. The CS of RAMULAB54 was profiled for organic acid that showed the abundance of hydroxycitric acid, citric acid, and lactic acid indicating their role in the observed inhibitory effects. The in silico approach has led us to understand that hydroxycitric acid has the ability to inhibit both the enzymes (α-glucosidase and α-amylase) effectively. Inhibiting these enzymes helps moderate postprandial hyperglycemia and regulates blood glucose levels. Due to their promising antidiabetic potential, these isolates can be used to enhance intestinal health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SaccharumProbioticsHumansHypoglycemic AgentsLacticaseibacillusalpha-GlucosidasesRNA, Ribosomal, 16Salpha-AmylasesCitrates

Stichwörter der Autor:innen

lactic acid bacteriaprobioticsugarcaneα-amylaseα-glucosidase

Substanzen

Hypoglycemic Agentsalpha-GlucosidasesRNA, Ribosomal, 16Salpha-Amylaseshydroxycitric acidCitrates

Autor:innen und Institutionen

  • Department of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysuru 570015, Karnataka, India.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Shaqra 11961, Saudi Arabia.
  • Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al Ahsa 31982, Saudi Arabia.
  • Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 42535, Saudi Arabia.
  • Department of Biomedical Science, College of Pharmacy, Shaqra University, Al-Dawadmi Campus, Shaqra 11961, Saudi Arabia.

ORCID-Profile: Chandana Kumari V B, Sujay S Huligere, Abdulaziz K Al Mouslem, Thippeswamy Boreddy Shivanandappa

Zitieren

APA

Kumari V B, C., Huligere, S. S., Alotaibi, G., Al Mouslem, A. K., Bahauddin, A. A., Shivanandappa, T. B., & Ramu, R. (2023). Antidiabetic Activity of Potential Probiotics Limosilactobacillus spp., Levilactobacillus spp., and Lacticaseibacillus spp. Isolated from Fermented Sugarcane Juice: A Comprehensive In Vitro and In Silico Study. Nutrients, 15(8), 1882. https://doi.org/10.3390/nu15081882

Vancouver

Kumari V B C, Huligere SS, Alotaibi G, Al Mouslem AK, Bahauddin AA, Shivanandappa TB, et al. Antidiabetic Activity of Potential Probiotics Limosilactobacillus spp., Levilactobacillus spp., and Lacticaseibacillus spp. Isolated from Fermented Sugarcane Juice: A Comprehensive In Vitro and In Silico Study. Nutrients. 2023;15(8):1882. doi:10.3390/nu15081882

BibTeX
@article{KumariVB2023,
  author = {Kumari V B, Chandana and Huligere, Sujay S and Alotaibi, Ghallab and Al Mouslem, Abdulaziz K and Bahauddin, Ammar Abdulraheem and Shivanandappa, Thippeswamy Boreddy and Ramu, Ramith},
  title = {Antidiabetic Activity of Potential Probiotics Limosilactobacillus spp., Levilactobacillus spp., and Lacticaseibacillus spp. Isolated from Fermented Sugarcane Juice: A Comprehensive In Vitro and In Silico Study},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {8},
  pages = {1882},
  doi = {10.3390/nu15081882}
}
Kostenlos starten →